Wilson Sonsini advised ArrePath on the deal. ArrePath, an anti-infective drug discovery company addressing drug resistant infections, announced it has raised $20 million in seed financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aramis Biosciences on the deal. Aramis Biosciences, a clinical-stage immuno-ophthalmology biopharmaceutical company, announced its launch and the completion of a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented General Atlantic on the transaction. CinCor Pharma, Inc. announced the completion of a $143 million Series B financing. The financing...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal. Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series...
You must be a Standard 1 Year member to access this content.
Wiersholm and Elvinger Hoss Prussen assisted Alussa Energy on the deal while Wilson Sonsini Goodrich & Rosati and Arendt have advised FREYR AS on the deal....
You must be a Standard 1 Year member to access this content.
